Form 4: Hims & Hers Health CFO Oluyemi Okupe Sells Shares Under 10b5-1 Trading Plan

Hims & Hers Health CFO Oluyemi Okupe sold 9,912 shares of Class A Common Stock on March 20, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On March 20, 2024, Oluyemi Okupe, the Chief Financial Officer of Hims & Hers Health, Inc. (HIMS), sold 9,912 shares of Class A Common Stock.
• The sales were executed under a Rule 10b5-1 trading plan adopted on May 10, 2023.
• The shares were sold in multiple transactions at prices ranging from $15.76 to $15.88, with weighted average prices of $15.8174, $15.8177, and $15.8275.
• Following the reported transactions, Okupe directly owns 168,627 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to stock sales by an executive. It doesn't inherently convey positive or negative sentiment, as the sales were pre-planned.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions. It's common for executives to use 10b5-1 trading plans to sell shares over time to avoid accusations of insider trading. The sale itself doesn't necessarily indicate a negative outlook on the company.

Stakeholder Impact

• The stock sale could have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.

Key Dates